Stay updated on SAR422459 in Stargardt's Macular Degeneration Clinical Trial
Sign up to get notified when there's something new on the SAR422459 in Stargardt's Macular Degeneration Clinical Trial page.

Latest updates to the SAR422459 in Stargardt's Macular Degeneration Clinical Trial page
- Check5 days agoChange DetectedLocations section updated to include Florida, Iowa, Oregon, and Texas. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedThe Publications section wording was updated to clarify that publications are auto-filled from PubMed, and the page revision was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check41 days agoChange DetectedThe government funding status notice was removed from the page, while the study details and other content remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedNo additions or deletions were observed on the page; the content appears unchanged.SummaryDifference0.4%

- Check84 days agoChange Detected- Added a government funding/operating status notice and a link for operating status updates. - Added a new resource: Stargardt disease under Genetic and Rare Diseases Information Center. - Updated revision from v3.1.0 to v3.2.0.SummaryDifference3%

- Check91 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.1%

Stay in the know with updates to SAR422459 in Stargardt's Macular Degeneration Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR422459 in Stargardt's Macular Degeneration Clinical Trial page.